ATXN3 and Huntington disease: Although there is no direct evidence for SCA1, activation of glucocorticoid receptors seems to attenuate the aggregation of polyQ-expanded ataxin-3 and huntingtin proteins in SCA3 and Huntington’s disease (HD), respectively [76,77].